Efficient expression of enterovirus 71 based on virus-like particles vaccine
暂无分享,去创建一个
H. Kim | G. Chung | Sang Won Lee | J. Yoo | Hosun Son | Youngsil Yoon | June-Woo Lee | Ji-Yeon Hyeon
[1] Qinjian Zhao,et al. Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins , 2015, Human vaccines & immunotherapeutics.
[2] J. Mascola,et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial , 2014, The Lancet.
[3] J. Heeney,et al. Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein , 2014, Journal of Biomedical Science.
[4] Jing-xin Li,et al. Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial , 2014, Human vaccines & immunotherapeutics.
[5] P. Woo,et al. Human enterovirus 71 epidemics: what's next? , 2013, Emerging health threats journal.
[6] D. Cheon,et al. Seroepidemiology of predominant norovirus strains circulating in Korea by using recombinant virus-like particle antigens. , 2013, Foodborne pathogens and disease.
[7] J. Galama,et al. persistent infections. application for diagnostic routine and reaction for detection of enteroviruses: General primer-mediated polymerase chain , 2013 .
[8] Suh-Chin Wu,et al. Production of EV71 vaccine candidates , 2012, Human vaccines & immunotherapeutics.
[9] Wenbo Xu,et al. The Persistent Circulation of Enterovirus 71 in People's Republic of China: Causing Emerging Nationwide Epidemics Since 2008 , 2011, PloS one.
[10] P. Mangeot,et al. A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques , 2011, Science Translational Medicine.
[11] P. Chong,et al. Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System , 2011, PloS one.
[12] Marianne Manchester,et al. Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[13] C. S. Chan YF, Sam IC and AbuBakar S. (2010). Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. Infection, Genetics and Evolution 10:404-412. , 2010 .
[14] Tom Solomon,et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. , 2010, The Lancet. Infectious diseases.
[15] W. Ryu,et al. Enterovirus 71 Infection with Central Nervous System Involvement, South Korea , 2010, Emerging infectious diseases.
[16] F. J. Geske,et al. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever , 2010, Virology Journal.
[17] Chi-Yuan Chen,et al. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. , 2010, Vaccine.
[18] Dingmei Zhang,et al. Enterovirus 71 vaccine: close but still far , 2010, International Journal of Infectious Diseases.
[19] I. Sam,et al. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[20] Sheng-Wen Huang,et al. Reemergence of Enterovirus 71 in 2008 in Taiwan: Dynamics of Genetic and Antigenic Evolution from 1998 to 2008 , 2009, Journal of Clinical Microbiology.
[21] Brian Megson,et al. Molecular Epidemiology of Human Enterovirus 71 in the United Kingdom from 1998 to 2006 , 2008, Journal of Clinical Microbiology.
[22] M. Ho,et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. , 2008, Vaccine.
[23] Chien-Fu Hung,et al. Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer , 2008, Biologics : targets & therapy.
[24] Chao A. Hsiung,et al. Temporal Transcription Program of Recombinant Autographa californica Multiple Nucleopolyhedrosis Virus , 2006, Journal of Virology.
[25] M. Pallansch,et al. Sensitive, Seminested PCR Amplification of VP1 Sequences for Direct Identification of All Enterovirus Serotypes from Original Clinical Specimens , 2006, Journal of Clinical Microbiology.
[26] M. Ho,et al. Expression, purification and characterization of enterovirus-71 virus-like particles. , 2006, World journal of gastroenterology.
[27] A. Bruu,et al. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and Newer Enteroviruses , 2003 .
[28] M. Pallansch,et al. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. , 1995, Virus research.
[29] M. Betenbaugh,et al. Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus. , 1995, Virus research.
[30] E. Snezhkov,et al. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein. , 1993, Virology.
[31] J. Galama,et al. General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections , 1992, Journal of clinical microbiology.
[32] D. Ritter,et al. Expression of largest RNA segment and synthesis of VP1 protein of bluetongue virus in insect cells by recombinant baculovirus: association of VP1 protein with RNA polymerase activity. , 1989, Nucleic acids research.